NASDAQ:SESN - Sesen Bio Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.88 -0.03 (-3.30 %)
(As of 03/24/2019 03:16 PM ET)
Previous Close$0.88
Today's Range$0.8550 - $0.91
52-Week Range$0.66 - $3.50
Volume1.16 million shs
Average Volume1.69 million shs
Market Capitalization$68.16 million
P/E RatioN/A
Dividend YieldN/A
Beta2.01
Sesen Bio, Inc., a late-stage clinical company, develops next-generation antibody-drug conjugate therapies for patients with cancer. It develops its products based on its Targeted Protein Therapeutics (TPTs) platform. The company's lead product candidate is Vicinium, a fusion protein that is in Phase III clinical trial for the treatment of high-grade non-muscle invasive bladder cancer. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trial for the treatment of high-grade non-muscle invasive bladder cancer; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. In addition, the company is developing systemically-administered TPTs, including VB6-845d for the treatment of solid tumors. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

Receive SESN News and Ratings via Email

Sign-up to receive the latest news and ratings for SESN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SESN
CUSIPN/A
CIKN/A
Phone617-444-8550

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$430,000.00
Book Value$0.57 per share

Profitability

Net Income$-33,690,000.00

Miscellaneous

EmployeesN/A
Market Cap$68.16 million
Next Earnings Date5/21/2019 (Estimated)
OptionableOptionable

Sesen Bio (NASDAQ:SESN) Frequently Asked Questions

What is Sesen Bio's stock symbol?

Sesen Bio trades on the NASDAQ under the ticker symbol "SESN."

How were Sesen Bio's earnings last quarter?

Sesen Bio Inc (NASDAQ:SESN) posted its quarterly earnings results on Monday, March, 4th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.01. View Sesen Bio's Earnings History.

When is Sesen Bio's next earnings date?

Sesen Bio is scheduled to release their next quarterly earnings announcement on Tuesday, May 21st 2019. View Earnings Estimates for Sesen Bio.

What price target have analysts set for SESN?

3 brokerages have issued 1 year price objectives for Sesen Bio's stock. Their forecasts range from $1.00 to $3.00. On average, they anticipate Sesen Bio's share price to reach $2.00 in the next year. This suggests a possible upside of 127.3% from the stock's current price. View Analyst Price Targets for Sesen Bio.

What is the consensus analysts' recommendation for Sesen Bio?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sesen Bio in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sesen Bio.

Has Sesen Bio been receiving favorable news coverage?

Media headlines about SESN stock have trended neutral recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sesen Bio earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the next several days.

Who are some of Sesen Bio's key competitors?

What other stocks do shareholders of Sesen Bio own?

Who are Sesen Bio's key executives?

Sesen Bio's management team includes the folowing people:
  • Mr. Richard F. Fitzgerald, CFO, Sec. & Treasurer (Age 55)
  • Dr. Thomas R. Cannell, Pres, CEO & Director (Age 57)
  • Dr. K. Christopher Garcia, Co-Founder & Member of Scientific Advisory Board
  • Dr. Gregory L. Verdine, Co-Founder (Age 60)
  • Dr. Casey T. Weaver, Co-Founder & Member of Scientific Advisory Board

Who are Sesen Bio's major shareholders?

Sesen Bio's stock is owned by many different of institutional and retail investors. Top institutional investors include Millennium Management LLC (1.42%), Hikari Power Ltd (0.26%), Pura Vida Investments LLC (0.26%), Dimensional Fund Advisors LP (0.25%), Jane Street Group LLC (0.04%) and Two Sigma Investments LP (0.03%).

Which major investors are buying Sesen Bio stock?

SESN stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Pura Vida Investments LLC, Hikari Power Ltd, Jane Street Group LLC, Two Sigma Investments LP and Dimensional Fund Advisors LP.

How do I buy shares of Sesen Bio?

Shares of SESN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sesen Bio's stock price today?

One share of SESN stock can currently be purchased for approximately $0.88.

How big of a company is Sesen Bio?

Sesen Bio has a market capitalization of $68.16 million and generates $430,000.00 in revenue each year. The company earns $-33,690,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

What is Sesen Bio's official website?

The official website for Sesen Bio is http://www.sesenbio.com.

How can I contact Sesen Bio?

Sesen Bio's mailing address is 245 FIRST STREET SUITE 1800, CAMBRIDGE MA, 02142. The company can be reached via phone at 617-444-8550 or via email at [email protected]


MarketBeat Community Rating for Sesen Bio (NASDAQ SESN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  109
MarketBeat's community ratings are surveys of what our community members think about Sesen Bio and other stocks. Vote "Outperform" if you believe SESN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SESN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel